RxDoctor Payments Data

Lea Nickolas

Primary Care · Avondale, AZNPI 1306471644

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 279 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Gilead at 39.9% of the total. Reporting peaked in 2023 at $2,325 and has fallen 83.1% since, to $392 in 2025. Among primary care clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,046in general payments, 2019–2025

Across 279 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$3K
  • Viiv Healthcare Company$2K
  • Johnson & Johnson$552
  • Merck$403
  • AbbVie$307
  • Janssen Products, LP$178
  • plus $486 from 14 others

What the payments were for

  • Food & beverage$6,98199%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,046 in reported general payments places this provider in the 95th percentile of 151 primary care providers in Arizona.

See all primary care providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala16$64,037
JardianceEmpagliflozin20$9,716
Albuterol Sulfate HfaAlbuterol Sulfate35$811
Diclofenac Sodium15$499
Omeprazole16$320
Trazodone Hcl40$287
Lisinopril48$269
Gabapentin15$266
Atorvastatin Calcium35$194
Fluticasone Propionate14$181
Metformin Hcl44$176
Rosuvastatin Calcium18$127
Amlodipine Besylate19$105
Levothyroxine Sodium15$94
Meloxicam14$93

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy$2,813$64,03716 claims
Boehringer IngelheimJardiance$46$9,71620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 151 primary care providers in Arizona.

Other primary care in Avondale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →